These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15120577

  • 1. Increased beta-secretase activity and expression in rats following transient cerebral ischemia.
    Wen Y, Onyewuchi O, Yang S, Liu R, Simpkins JW.
    Brain Res; 2004 May 29; 1009(1-2):1-8. PubMed ID: 15120577
    [Abstract] [Full Text] [Related]

  • 2. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S, Price EA, Wu G, Crouthamel MC, Shi XP, Tugusheva K, Tyler KX, Kahana J, Ellis J, Jin L, Steele T, Stachel S, Coburn C, Simon AJ.
    J Pharmacol Exp Ther; 2008 Mar 29; 324(3):957-69. PubMed ID: 18156464
    [Abstract] [Full Text] [Related]

  • 3. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
    Stockley JH, O'Neill C.
    Biochem Soc Trans; 2007 Jun 29; 35(Pt 3):574-6. PubMed ID: 17511655
    [Abstract] [Full Text] [Related]

  • 4. Caspase inhibition attenuates accumulation of beta-amyloid by reducing beta-secretase production and activity in rat brains after stroke.
    Xiong M, Zhang T, Zhang LM, Lu SD, Huang YL, Sun FY.
    Neurobiol Dis; 2008 Dec 29; 32(3):433-41. PubMed ID: 18805488
    [Abstract] [Full Text] [Related]

  • 5. Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus.
    Hiltunen M, Mäkinen P, Peräniemi S, Sivenius J, van Groen T, Soininen H, Jolkkonen J.
    Neurobiol Dis; 2009 Jul 29; 35(1):103-13. PubMed ID: 19426802
    [Abstract] [Full Text] [Related]

  • 6. Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain.
    Stockley JH, Ravid R, O'Neill C.
    FEBS Lett; 2006 Dec 11; 580(28-29):6550-60. PubMed ID: 17113083
    [Abstract] [Full Text] [Related]

  • 7. Possible involvement of NO/NOS signaling in hippocampal amyloid-beta production induced by transient focal cerebral ischemia in aged rats.
    Li S, Wang W, Wang C, Tang YY.
    Neurosci Lett; 2010 Feb 12; 470(2):106-10. PubMed ID: 20043977
    [Abstract] [Full Text] [Related]

  • 8. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
    Cheon MS, Dierssen M, Kim SH, Lubec G.
    Amino Acids; 2008 Aug 12; 35(2):339-43. PubMed ID: 18163181
    [Abstract] [Full Text] [Related]

  • 9. Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains.
    Harada H, Tamaoka A, Ishii K, Shoji S, Kametaka S, Kametani F, Saito Y, Murayama S.
    Neurosci Res; 2006 Jan 12; 54(1):24-9. PubMed ID: 16290302
    [Abstract] [Full Text] [Related]

  • 10. beta-Secretase, APP and Abeta in Alzheimer's disease.
    Vassar R.
    Subcell Biochem; 2005 Jan 12; 38():79-103. PubMed ID: 15709474
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Presenilin 1 is involved in the maturation of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1).
    Kuzuya A, Uemura K, Kitagawa N, Aoyagi N, Kihara T, Ninomiya H, Ishiura S, Takahashi R, Shimohama S.
    J Neurosci Res; 2007 Jan 12; 85(1):153-65. PubMed ID: 17075903
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.
    Nishitomi K, Sakaguchi G, Horikoshi Y, Gray AJ, Maeda M, Hirata-Fukae C, Becker AG, Hosono M, Sakaguchi I, Minami SS, Nakajima Y, Li HF, Takeyama C, Kihara T, Ota A, Wong PC, Aisen PS, Kato A, Kinoshita N, Matsuoka Y.
    J Neurochem; 2006 Dec 12; 99(6):1555-63. PubMed ID: 17083447
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE, Thompson LA, Toyn JH, Marcin L, Barten DM, Marcinkeviciene J, Kopcho L, Kim Y, Lin A, Guss V, Burton C, Iben L, Polson C, Cantone J, Ford M, Drexler D, Fiedler T, Lentz KA, Grace JE, Kolb J, Corsa J, Pierdomenico M, Jones K, Olson RE, Macor JE, Albright CF.
    J Pharmacol Exp Ther; 2008 Aug 12; 326(2):502-13. PubMed ID: 18499745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.